Last news
Workers have a say on digital rules through collective bargaining

Workers have a say on digital rules through collective bargaining

BEIJING, Nov. 2, 2025 /PRNewswire/ -- A news report from China Daily: A nationwide initiative led by the All-China Federation of Trade Unions has made strides this year, using a "centralized collective bargaining" campaign between platform companies...

GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'

GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'

YONGIN, South Korea, Nov. 3, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been...

Mouser to Showcase Next-Gen Automation at VIMF 2025

Mouser to Showcase Next-Gen Automation at VIMF 2025

SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- Mouser Electronics, Inc., the industry's leading New Product Introduction (NPI) distributor with the widest selection of semiconductors and electronic components™, is pleased to announce its participation in...

HTX Wins "Web3 Venture Capital Fund of the Year" Award at Blockchain Life 2025

HTX Wins "Web3 Venture Capital Fund of the Year" Award at Blockchain Life 2025

PANAMA CITY, Nov. 3, 2025 /PRNewswire/ -- Global leading cryptocurrency exchange HTX made a commanding appearance at Blockchain Life 2025 in Dubai from October 28-29, serving as a Sapphire sponsor. The two-day summit gathered leaders, institutional...

Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer

Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer

HONG KONG, Nov. 3, 2025 /PRNewswire/ -- Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for first-line treatment of triple-negative breast cancer...

MALAYSIA HEALTHCARE TRAVEL COUNCIL STRENGHTENS REGIONAL PRESENCE IN MEDAN THROUGH ASTINDO TRAVEL FAIR 2025

MALAYSIA HEALTHCARE TRAVEL COUNCIL STRENGHTENS REGIONAL PRESENCE IN MEDAN THROUGH ASTINDO TRAVEL FAIR 2025

MEDAN, Indonesia, Nov. 3, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) continues to advance its regional outreach by participating in the ASTINDO Travel Fair (ATF) 2025, held in Medan, Indonesia. The event serves as one of the...

Legal Innovation Asia 2026 Report Reveals GenAI Transforming Legal Work, But Human Expertise Remains Central

Legal Innovation Asia 2026 Report Reveals GenAI Transforming Legal Work, But Human Expertise Remains Central

- Generative AI is transforming legal work - Technology adoption depends on education, and leadership buy-in - Technology matters — but people skills matter more SINGAPORE, Nov. 3, 2025 /PRNewswire/ -- A newly released report, Legal Innovation Asia...

OMANI PATIENTS GAIN DIRECT ACCESS TO MALAYSIAN MEDICAL SPECIALISTS THROUGH WEEK-LONG HEALTHCARE ACTIVATION

OMANI PATIENTS GAIN DIRECT ACCESS TO MALAYSIAN MEDICAL SPECIALISTS THROUGH WEEK-LONG HEALTHCARE ACTIVATION

SEEB, Oman, Nov. 3, 2025 /PRNewswire/ -- Malaysia Healthcare Week opens at City Centre Mall, Seeb, marking the first major Middle East activation under the Malaysia Year of Medical Tourism (MYMT) 2026. The week-long programme connects Omani patients...

1 ... 366 367 368 369 370 371 372 373 374 ... 3380
menu
menu